ArticleTechnology in cancer research & treatment
Comparison of Post-Resistance Treatment Outcomes in EGFR-Mutated NSCLC Patients Following Third-Generation EGFR-TKI Therapy: A Retrospective Cohort Study.
Xinyue Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.